We provide the appropriate facilities and professional support so that
researchers
can carry out their clinical trials, providing sponsors with a rapid and quality
response.
Management and professionalism, which
allow to increase the speed and
consistency of the results:
SPONSOR: GSK
STUDY: B WELL 1 / 202009
CONDITION: Chronic hepatitis B treated with nucleoside/nucleotide analogs
DRUG:
STATUS: Enrolling
ENROLLMENT TARGET:
OVERCOME: 3
SPONSOR: Eli Lilly
STUDY: J3L-MC-EZEF / ACCLAIM-Lp(a)
CONDITION: Atherosclerotic cardiovascular disease
DRUG:
STATUS: Enrolling
ENROLLMENT TARGET: 4
OVERCOME: 5
SPONSOR: Eli Lilly
STUDY: ACHIEVE-4 / J2A-MC-GZGS
CONDITION: Type 2 diabetes and obesity or overweight, with increased
cardiovascular risk
DRUG: LY3502970 administered once daily compared to insulin glargine